IRCT20151122025191N2
Not yet recruiting
Phase 3
Effect of memantine on cognitive impairments after ECT in elderly with major depressive disorder: a randomized double-blind placebo-controlled clinical trial
Overview
- Phase
- Phase 3
- Status
- Not yet recruiting
- Enrollment
- 40
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 60 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •Diagnosis of Major Depressive Disorder
- •Clinical Indication for Electroconvulsive Therapy
Exclusion Criteria
- •Diagnosis of Dementia
- •Diagnosis of Delirium
- •Hx of Major Axis I disorder(Schizophrenia, Schizoaffective, Bipolar I,II )
- •Medical contraindication
Investigators
Similar Trials
Recruiting
Phase 3
Evaluation of the effect of Memantine in patients with brain tumorsCognitive Impairment.Mild cognitive impairment, so statedG31.84IRCT20211029052903N1Esfahan University of Medical Sciences70
Completed
Phase 3
Effect of Memantine on epileptic patientsEpilepsy.Epilepsy and recurrent seizuresIRCT20121110011424N5Tehran University of Medical Sciences60
Completed
Phase 1
Memantine effect on patients with schizophreniaSchizophrenia.SchizophreniaIRCT20190606043827N1Kashan University of Medical Sciences50
Unknown
Not Applicable
Efficacy of Memantine on Cognitive Performance of Patients Under Electro Convulsive TherapyIRCT2013072314122N1Kurdistan University of Medical Sciences40
Active, not recruiting
Not Applicable
Can memantine prevent memory impairment induced by MDMA in humans - Memantine-MDMAEUCTR2010-024543-33-NLMaastricht University